Hair Colour and Texture Changes on Immunotherapy — Why Hair Turns White

No. On its own, hair turning white or grey on immunotherapy is a pigment change, not a dangerous reaction. It does not hurt, it does not spread inside the body, and it is not a sign the cancer has grown. What does need same-day attention is a skin change that is painful, blistering, peeling or spreading fast.

Immunotherapy sharpens the immune system's ability to recognise a marker on certain cells. The pigment cells that colour your hair and skin carry some of the same markers. When the immune system acts on them, colour stops being added to the growing hair. The hair itself stays healthy. It simply grows in white.

This is why the change appears at the root first and travels outwards as the hair grows. It is also why the same person often notices pale patches on the skin around the same time — the pigment cells in skin and hair are the same family of cells. NCCN and ASCO guidance on immune-related adverse events group these together as skin reactions to immunotherapy. They are described as low grade, meaning they usually do not require treatment to be paused or changed. That is a clinical judgement your own oncologist makes for you, not a rule you should apply yourself.

Pigment changes are late reactions, not first-week ones. White or grey hair is usually noticed two to six months in, because the hair has to grow out before the change shows. Pale skin patches appear in a similar window. Texture changes and eyebrow or eyelash whitening are noticed later still.

These are typical patterns described in NCCN and ASCO guidance on immune-related adverse events, not fixed rules. A change that appears outside its usual window is still worth reporting, and anything painful, blistering or fast-spreading is handled as urgent whenever it appears.

No. Immunotherapy given on its own does not usually cause the complete hair loss people associate with chemotherapy. Most patients keep their hair. Mild thinning happens in some people, and small round patches of loss are an uncommon immune reaction. Ask which drugs are in your own plan.

This distinction matters more than it sounds. Families who have watched a relative go through chemotherapy often brace for the same thing, and the fear of visible hair loss puts some patients off treatment before they have understood what is actually being offered. If your plan combines immunotherapy with chemotherapy, any major hair loss is coming from the chemotherapy part, and your oncologist can tell you which of the two is responsible for what. That single question — "which of these drugs causes hair loss?" — is worth asking at your 45-minute consultation.

Often it does not. Pigment loss in hair and skin can be long lasting and may be permanent, even after treatment finishes. Some people see patches of colour return over months or years. Texture is different — hair that turned curlier, coarser or finer usually settles back once treatment ends.

There is no way to predict who regains colour and who does not, and no test that answers it in advance. Thinning and patchy loss usually regrow, though the new hair may come back a different colour or texture from before. We would rather tell you this at the start than let you wait two years for a change that may not come. Knowing it is permanent is also what lets people decide, calmly, whether they want to colour their hair, cut it shorter, or simply leave it — a decision that belongs to you, not to us.

You cannot read it that way. Doctors have observed that skin and hair depigmentation appears more often in some patients who respond, particularly in melanoma. That observation has never become a test. It is not used to decide whether to continue, change or stop treatment, and it is not a signal you can act on.

The reason matters. Plenty of patients whose treatment is working never change colour at all, and reading an absence of white hair as bad news is exactly the kind of worry that keeps a family awake for nothing. It also runs the other way: nobody should feel reassured enough by white hair to skip a scan. Response is judged on imaging and on your oncologist's assessment, discussed at a tumour board — not on your hairline. If someone has told you otherwise, bring it up at your next visit and get it settled.

Report it, photograph it, and ask before you use anything on it. A colour change alone does not need an emergency visit or a change to your treatment. It does belong in your record, because your team tracks skin reactions over time and a new one can appear alongside an old one.

1. 1

   Tell your oncology team at your next visit

   Say when you first noticed it and whether it is still spreading. Immunotherapy at CION is given as day care, so there is a review point at every cycle.

2. 2

   Photograph it in daylight with the date

   A photo from a month ago tells your doctor more than any description. Include the scalp, the face and the hands.

3. 3

   Ask before using any hair or scalp product

   Dyes, bleaches, herbal and ayurvedic preparations, oils and hair supplements all go past your team first. Tell them about anything you have already used, without worrying about being judged for it.

4. 4

   Ask about sun protection for pale skin patches

   Skin that has lost pigment burns more easily than the skin around it. Your team will tell you what is appropriate for you.

5. 5

   Ask for a dermatology review if it is spreading or symptomatic

   Your oncology team arranges this. Pale patches that itch, sting or spread quickly are worth a specialist look.

6. 6

   Say so if the change is upsetting you

   For a young adult especially, a visible change can be harder than the treatment itself. CION has a psycho-oncologist for exactly this, and asking is not vanity.

Hair and pigment changes are the quiet end of a range of skin reactions on immunotherapy. Knowing which changes are cosmetic and which need a same-day call is what stops a family either panicking early or waiting too long.

• Will the Skin Changes Go Away After Treatment Ends? — the same reversibility question, answered across every skin change, not just hair.
• Nail Changes During Immunotherapy — nails often change in the same months as hair, and are missed for the same reason.
• Rash on Immunotherapy: What Is Normal and What Is Not — read this if there is a rash as well as a colour change; it sets the line for what needs a same-day call.
• Immunotherapy at CION Cancer Clinics — how our tumour board monitors for immune reactions from the first day-care infusion onward.

Skin and Hair Changes Are Reviewed at Every Cycle

Patients on immunotherapy at CION are told which changes are expected and which need same-day attention, at every day-care visit.